Past Meeting | Keystone Symposia

This meeting took place in the past. Here is a list of meetings that are related:
Diabetes: Glucose Control and Beyond (2020J5)

Web Desc
Uncomplicating Diabetes: Reducing the Burden of Diabetes-Related End-Organ Injury joint with Vascular Biology and Human Diseases: From Molecular Pathways to Novel Therapeutics Organizer(s): Mark E. Cooper, Thomas M. Coffman, Matthias G. von Herrath and Susan Quaggin Date: February 25 - March 01, 2018 Location: Eldorado Hotel & Spa, Santa Fe, NM, USA Sponsored by Novo Nordisk A/S Summary of Meeting: This Keystone Symposia conference will address diabetic complications which remain the major cause of morbidity and mortality in the diabetic population. Although the outlook has improved over the last two decades with respect to diabetic vascular disease, these complications remain a major burden with the underlying explanation for these complications at a molecular and cellular level as yet not fully clarified. With recent advances in the management of diabetes, particularly new classes of glucose-lowering agents, it is critical to determine if these new therapies have both glucose-dependent and independent effects in reducing diabetes-related end-organ injury. With major advances in our understanding of key pathological features of diabetic complications such as angiogenesis, fibrosis, inflammation and vascular remodeling, albeit in non-diabetic contexts, now is the time to translate this new knowledge to the field of diabetic complications. By learning from and recruiting such researchers into the field of diabetic complications, there is a great opportunity to develop novel, highly innovative approaches to identify new targets in order to discover new ways to treat, reverse or prevent diabetic complications that lead to premature atherosclerosis, heart failure, blindness, cognitive impairment and end-stage renal disease. Scholarship Deadline: November 16 2017 Discounted Abstract Deadline: November 16 2017 Abstract Deadline: November 28 2017 Discounted Registration Deadline: December 20 2017 Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting: We gratefully acknowledge additional support for this conference from: Diabetic Complications Consortium We gratefully acknowledge the generous grant for this conference provided by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant No. 1 R13 DK116595-01 Funding for this conference was made possible (in part) by 1 R13 DK116595-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising: Click here to view more of these organizations Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds: Click here to view more of these organizations

Web Desc

Uncomplicating Diabetes: Reducing the Burden of Diabetes-Related End-Organ Injury

joint with Vascular Biology and Human Diseases: From Molecular Pathways to Novel Therapeutics

Organizer(s): Mark E. Cooper, Thomas M. Coffman, Matthias G. von Herrath and Susan Quaggin

Date: February 25 - March 01, 2018
Location: Eldorado Hotel & Spa, Santa Fe, NM, USA

Program


Sunday, February 25 \| 4:00PM - 8:00PM Arrival and Registration Room: Eldorado Lounge
Sunday, February 25 \| 6:00PM - 8:00PM Welcome Mixer Room: Eldorado Lounge No registration fees are used to fund alcohol served at this function.
Monday, February 26 \| 7:00AM - 8:00AM Breakfast Room: Anasazi Ballroom
Monday, February 26 \| 8:00AM - 9:00AM Welcome and Keynote Address Room: Eldorado B Speaker 1 of 2 * Daniel J. Drucker, Lunenfeld-Tanenbaum Research Institute, Canada
Monday, February 26 \| 8:00AM - 9:00AM Welcome and Keynote Address Room: Eldorado B Speaker 2 of 2 Steven E. Kahn, University of Washington, USA Current Management of Type 2 Diabetes
Monday, February 26 \| 9:00AM - 11:30AM New Treatments in Diabetes Room: Eldorado B Speaker 1 of 7 * Mark I. McCarthy, University of Oxford, UK
Monday, February 26 \| 9:00AM - 11:30AM New Treatments in Diabetes Room: Eldorado B Speaker 2 of 7 Daniel J. Drucker, Lunenfeld-Tanenbaum Research Institute, Canada GLP-1-Mediated Reduction in Complications of Diabetes
Monday, February 26 \| 9:00AM - 11:30AM New Treatments in Diabetes Room: Eldorado B Coffee Break
Monday, February 26 \| 9:00AM - 11:30AM New Treatments in Diabetes Room: Eldorado B Speaker 4 of 7 Volker Vallon, University of California, San Diego, USA SGLT2 Inhibition – Insights from Experimental Studies
Monday, February 26 \| 9:00AM - 11:30AM New Treatments in Diabetes Room: Eldorado B Speaker 5 of 7 David Cherney, University of Toronto, Canada SGLT2 Inhibition: Renal Effects in Man
Monday, February 26 \| 9:00AM - 11:30AM New Treatments in Diabetes Room: Eldorado B Speaker 6 of 7 * Simeon Taylor, University of Maryland School of Medicine, USA Short Talk: Canagliflozin Triggers the FGF23/1,25-dihydroxyvitamin/PTH Axis: A Potential Mechanism Mediating Adverse Effects on Bone Health
Monday, February 26 \| 9:00AM - 11:30AM New Treatments in Diabetes Room: Eldorado B Speaker 7 of 7 Anita C. Aperia, Karolinska Institute, Sweden Short Talk: Vulnerability of SGLT-Expressing Cells to Hyperglycaemia
Monday, February 26 \| 9:00AM - 11:30AM Vascular Growth Factors: Biological Relevance and Therapeuti c Application This session is from Vascular Biology Room: Eldorado A Speaker 1 of 7 * Anne C. Eichmann, Yale University School of Medicine, USA
Monday, February 26 \| 9:00AM - 11:30AM Vascular Growth Factors: Biological Relevance and Therapeuti c Application This session is from Vascular Biology Room: Eldorado A Speaker 2 of 7 Michael Simons, Yale University, USA Cell Type Specificity of FGF/TGF Signaling
Monday, February 26 \| 9:00AM - 11:30AM Vascular Growth Factors: Biological Relevance and Therapeuti c Application This session is from Vascular Biology Room: Eldorado A Coffee Break
Monday, February 26 \| 9:00AM - 11:30AM Vascular Growth Factors: Biological Relevance and Therapeuti c Application This session is from Vascular Biology Room: Eldorado A Speaker 4 of 7 Lena Claesson-Welsh, Uppsala University, Sweden Vascular Leakage in Cancer and Retinopathy
Monday, February 26 \| 9:00AM - 11:30AM Vascular Growth Factors: Biological Relevance and Therapeuti c Application This session is from Vascular Biology Room: Eldorado A Speaker 5 of 7 Shahin Rafii, Weill Cornell Medical College, USA Ultradian Vascular Niche Signals in Organotypic Stem Cell Regeneration
Monday, February 26 \| 9:00AM - 11:30AM Vascular Growth Factors: Biological Relevance and Therapeuti c Application This session is from Vascular Biology Room: Eldorado A Speaker 6 of 7 Anna I. Dimberg, Uppsala University Hospital, Sweden Short Talk: CD93 in Regulation of Tumor Angiogenesis
Monday, February 26 \| 9:00AM - 11:30AM Vascular Growth Factors: Biological Relevance and Therapeuti c Application This session is from Vascular Biology Room: Eldorado A Speaker 7 of 7 Roxana Ola, Yale University, USA Short Talk: Smad4 Acts Downstream of BMP9/10-ALK1 in Mediating AVM Formation through Transcriptional Modulation of CK2/PTEN/PI3K Signaling Cascade
Monday, February 26 \| 11:30AM - 5:00PM On Own for Lunch
Monday, February 26 \| 11:30AM - 1:00PM Poster Setup Room: Anasazi Ballroom
Monday, February 26 \| 1:00PM - 10:00PM Poster Viewing Room: Anasazi Ballroom
Monday, February 26 \| 4:30PM - 5:00PM Coffee Available Room: Concourse
Monday, February 26 \| 5:00PM - 7:00PM Lipids and Diabetic Complications Room: Eldorado B Speaker 1 of 5 * Moshe Levi, Georgetown University, USA
Monday, February 26 \| 5:00PM - 7:00PM Lipids and Diabetic Complications Room: Eldorado B Speaker 2 of 5 * Josephine Forbes, University of Queensland, Australia
Monday, February 26 \| 5:00PM - 7:00PM Lipids and Diabetic Complications Room: Eldorado B Speaker 3 of 5 Katalin Susztak, University of Pennsylvania, USA How to Turn GWAS Signals into Drugs for Kidney Disease?
Monday, February 26 \| 5:00PM - 7:00PM Lipids and Diabetic Complications Room: Eldorado B Speaker 4 of 5 Weier Qi, Joslin Diabetes Center, Harvard Medical School, Boston, USA, Sweden Human Proteomics to Therapeutics for Diabetic Nephropathy - The 50-Year Joslin Medalist Study
Monday, February 26 \| 5:00PM - 7:00PM Lipids and Diabetic Complications Room: Eldorado B Speaker 5 of 5 Eoin P. Brennan, Conway Institute, Ireland Short Talk: Targeting Inflammation in Diabetic Kidney Disease Using Pro-Resolving Lipid Mediators
Monday, February 26 \| 5:00PM - 7:00PM Vascular Growth Factors: Receptors and Biological Role This session is from Vascular Biology Room: Eldorado A Speaker 1 of 5 * Lena Claesson-Welsh, Uppsala University, Sweden
Monday, February 26 \| 5:00PM - 7:00PM Vascular Growth Factors: Receptors and Biological Role This session is from Vascular Biology Room: Eldorado A Speaker 2 of 5 Gou Young Koh, Institute of Basic Science, South Korea Tie2-Activating Antibody “ABTAA” for Micro-vascular Diseases
Monday, February 26 \| 5:00PM - 7:00PM Vascular Growth Factors: Receptors and Biological Role This session is from Vascular Biology Room: Eldorado A Speaker 3 of 5 Gavin O. Thurston, Regeneron Pharmaceuticals Inc., USA Tumor Endothelial Cell Heterogeneity and Responses to Anti-Vascular Therapy
Monday, February 26 \| 5:00PM - 7:00PM Vascular Growth Factors: Receptors and Biological Role This session is from Vascular Biology Room: Eldorado A Speaker 4 of 5 Luisa Iruela-Arispe, University of California, Los Angeles, USA Critical Signaling Nodes in Vascular Homeostasis
Monday, February 26 \| 5:00PM - 7:00PM Vascular Growth Factors: Receptors and Biological Role This session is from Vascular Biology Room: Eldorado A Speaker 5 of 5 Hong Chen, Harvard Medical School, USA Short Talk: Epsin’s Role in Diabetic Lymphanagiogenesis
Monday, February 26 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Anasazi Ballroom No registration fees are used to fund alcohol served at this function.
Monday, February 26 \| 7:30PM - 10:00PM Poster Session 1 Room: Anasazi Ballroom
Tuesday, February 27 \| 7:00AM - 8:00AM Breakfast Room: Anasazi Ballroom
Tuesday, February 27 \| 8:00AM - 11:15AM Endothelial Metabolism and Neurovascular Cross-Talk (Joint) Room: Eldorado Grand Ballroom Speaker 1 of 9 * George L. King, Joslin Diabetes Center, USA
Tuesday, February 27 \| 8:00AM - 11:15AM Endothelial Metabolism and Neurovascular Cross-Talk (Joint) Room: Eldorado Grand Ballroom Speaker 2 of 9 * Luisa Iruela-Arispe, University of California, Los Angeles, USA
Tuesday, February 27 \| 8:00AM - 11:15AM Endothelial Metabolism and Neurovascular Cross-Talk (Joint) Room: Eldorado Grand Ballroom Speaker 3 of 9 Peter F. Carmeliet, University of Leuven, VIB, Belgium Endothelial Cell Metabolism and Therapeutic Interventions
Tuesday, February 27 \| 8:00AM - 11:15AM Endothelial Metabolism and Neurovascular Cross-Talk (Joint) Room: Eldorado Grand Ballroom Speaker 4 of 9 Susan Quaggin, Northwestern University, USA VE-PTP Phosphatase Inhibition Protects the Kidney in Diabetes
Tuesday, February 27 \| 8:00AM - 11:15AM Endothelial Metabolism and Neurovascular Cross-Talk (Joint) Room: Eldorado Grand Ballroom Coffee Break
Tuesday, February 27 \| 8:00AM - 11:15AM Endothelial Metabolism and Neurovascular Cross-Talk (Joint) Room: Eldorado Grand Ballroom Speaker 6 of 9 Anne C. Eichmann, Yale University School of Medicine, USA Neurovascular Cross-Talk and Possible Pathological Implications
Tuesday, February 27 \| 8:00AM - 11:15AM Endothelial Metabolism and Neurovascular Cross-Talk (Joint) Room: Eldorado Grand Ballroom Speaker 7 of 9 David L. Silver, Duke-NUS Medical School, Singapore Brain Lipid Transport
Tuesday, February 27 \| 8:00AM - 11:15AM Endothelial Metabolism and Neurovascular Cross-Talk (Joint) Room: Eldorado Grand Ballroom Speaker 8 of 9 Kevin G. Peters, Aerpio Pharmaceuticals, USA Short Talk: Targeting VE-PTP for Tie2 Activation and Vascular Stabilization in Diabetic Eye Disease
Tuesday, February 27 \| 8:00AM - 11:15AM Endothelial Metabolism and Neurovascular Cross-Talk (Joint) Room: Eldorado Grand Ballroom Speaker 9 of 9 Jacqueline A. Taylor, German Cancer Research Center, Germany Short Talk: Endothelial Notch1 Is a Potent Regulator of Adipose Tissue Metabolism and Function
Tuesday, February 27 \| 11:15AM - 5:00PM On Own for Lunch
Tuesday, February 27 \| 11:15AM - 1:00PM Poster Setup Room: Anasazi Ballroom
Tuesday, February 27 \| 1:00PM - 10:00PM Poster Viewing Room: Anasazi Ballroom
Tuesday, February 27 \| 4:30PM - 5:00PM Coffee Available Room: Concourse
Tuesday, February 27 \| 5:00PM - 7:15PM Mitochondria and Diabetic Complications Room: Eldorado B Speaker 1 of 6 * Kumar Sharma, USA
Tuesday, February 27 \| 5:00PM - 7:15PM Mitochondria and Diabetic Complications Room: Eldorado B Speaker 2 of 6 * Assaad Antoine Eid, American University of Beirut, Lebanon
Tuesday, February 27 \| 5:00PM - 7:15PM Mitochondria and Diabetic Complications Room: Eldorado B Speaker 3 of 6 Richard J. Youle, NINDS, National Institutes of Health, USA General Overview on Mito Maven
Tuesday, February 27 \| 5:00PM - 7:15PM Mitochondria and Diabetic Complications Room: Eldorado B Speaker 4 of 6 Chengxue Helena Qin, Baker IDI Heart and Diabetes Institute, Australia Role of Endogenous Annexin-A1 in the Cardiovascular Response to Diabetes
Tuesday, February 27 \| 5:00PM - 7:15PM Mitochondria and Diabetic Complications Room: Eldorado B Speaker 5 of 6 Farhad Danesh, University of Texas MD Anderson Cancer Center, USA Mitochondrial Reprogramming in Diabetic Nephropathy
Tuesday, February 27 \| 5:00PM - 7:15PM Mitochondria and Diabetic Complications Room: Eldorado B Speaker 6 of 6 Svati H. Shah, Duke University, USA What Can We Learn from Metabolomics?
Tuesday, February 27 \| 5:00PM - 7:00PM Regulation of Endothelial Cell Differentiation in Developmen t and Tissue Regeneration This session is from Vascular Biology Room: Eldorado A Speaker 1 of 5 * Ralf H. Adams, Max Planck Institute for Molecular Biomedicine, Germany
Tuesday, February 27 \| 5:00PM - 7:00PM Regulation of Endothelial Cell Differentiation in Developmen t and Tissue Regeneration This session is from Vascular Biology Room: Eldorado A Speaker 2 of 5 Didier Stainier, Max Planck Institute for Heart and Lung Research, Germany Vascular Development in Zebrafish
Tuesday, February 27 \| 5:00PM - 7:00PM Regulation of Endothelial Cell Differentiation in Developmen t and Tissue Regeneration This session is from Vascular Biology Room: Eldorado A Speaker 3 of 5 Taija Mäkinen, Uppsala University, Sweden Mechanisms of Lymphatic Vessel Formation from Progenitors of Different Origins
Tuesday, February 27 \| 5:00PM - 7:00PM Regulation of Endothelial Cell Differentiation in Developmen t and Tissue Regeneration This session is from Vascular Biology Room: Eldorado A Speaker 4 of 5 Hellmut G. Augustin, DKFZ & Heidelberg University, Germany Epigenetic Regulation of Vascular Maturation
Tuesday, February 27 \| 5:00PM - 7:00PM Regulation of Endothelial Cell Differentiation in Developmen t and Tissue Regeneration This session is from Vascular Biology Room: Eldorado A Speaker 5 of 5 Katsuhiro Kato, Max Planck Institute for Molecular Biomedicine, Germany Short Talk: Pulmonary Pericytes Regulate Lung Morphogenesis
Tuesday, February 27 \| 7:15PM - 8:15PM Social Hour with Lite Bites Room: Anasazi Ballroom No registration fees are used to fund alcohol served at this function.
Tuesday, February 27 \| 7:30PM - 10:00PM Poster Session 2 Room: Anasazi Ballroom
Wednesday, February 28 \| 7:00AM - 8:00AM Breakfast Room: Anasazi Ballroom
Wednesday, February 28 \| 8:00AM - 11:00AM Genomics and Epigenomics in Diabetic Complications Room: Eldorado B Speaker 1 of 7 * Katalin Susztak, University of Pennsylvania, USA
Wednesday, February 28 \| 8:00AM - 11:00AM Genomics and Epigenomics in Diabetic Complications Room: Eldorado B Speaker 2 of 7 * Matthias G. von Herrath, Novo Nordisk and La Jolla Institute for Allergy and Immunology, USA
Wednesday, February 28 \| 8:00AM - 11:00AM Genomics and Epigenomics in Diabetic Complications Room: Eldorado B Speaker 3 of 7 Eske Willerslev, University of Copenhagen, Denmark DNA Research on Indigenous Populations
Wednesday, February 28 \| 8:00AM - 11:00AM Genomics and Epigenomics in Diabetic Complications Room: Eldorado B Speaker 4 of 7 Mark I. McCarthy, University of Oxford, UK Using Human Genetics for Biological Insight and Translational Advantage
Wednesday, February 28 \| 8:00AM - 11:00AM Genomics and Epigenomics in Diabetic Complications Room: Eldorado B Coffee Break
Wednesday, February 28 \| 8:00AM - 11:00AM Genomics and Epigenomics in Diabetic Complications Room: Eldorado B Speaker 6 of 7 Ariela Benigni, Istituto di Ricerche Farmacologiche Mario Negri, Italy Regeneration of Kidney Vasculature by Angiotensin II Antagonism: New Insights
Wednesday, February 28 \| 8:00AM - 11:00AM Genomics and Epigenomics in Diabetic Complications Room: Eldorado B Speaker 7 of 7 Assam El-Osta, Monash University, Australia Epigenetics of Diabetes and its Complications: Beyond Epiphenomenon?
Wednesday, February 28 \| 8:00AM - 11:15AM Molecular Basis of Vascular Diversity This session is from Vascular Biology Room: Eldorado A Speaker 1 of 8 * Hellmut G. Augustin, DKFZ & Heidelberg University, Germany
Wednesday, February 28 \| 8:00AM - 11:15AM Molecular Basis of Vascular Diversity This session is from Vascular Biology Room: Eldorado A Speaker 2 of 8 Ralf H. Adams, Max Planck Institute for Molecular Biomedicine, Germany Organ-Specific and Functional Specialization of Blood Vessels
Wednesday, February 28 \| 8:00AM - 11:15AM Molecular Basis of Vascular Diversity This session is from Vascular Biology Room: Eldorado A Speaker 3 of 8 Costantino Iadecola, Weill Cornell Medicine, USA The Diversity of the Brain Microcirculation in Health and Disease
Wednesday, February 28 \| 8:00AM - 11:15AM Molecular Basis of Vascular Diversity This session is from Vascular Biology Room: Eldorado A Coffee Break
Wednesday, February 28 \| 8:00AM - 11:15AM Molecular Basis of Vascular Diversity This session is from Vascular Biology Room: Eldorado A Speaker 5 of 8 Britta Engelhardt, Theodor Kocher Institute/Universitat Bern, Switzerland Specialized Brain Barriers Establish the Immune Privilege of the CNS
Wednesday, February 28 \| 8:00AM - 11:15AM Molecular Basis of Vascular Diversity This session is from Vascular Biology Room: Eldorado A Speaker 6 of 8 Stefan Liebner, Klinikum der Johann Wolfgang Goethe-Universität, Germany Role of Astrocyte-derived Wnt Growth Factors for Endothelial Blood-brain Barrier Maintenance
Wednesday, February 28 \| 8:00AM - 11:15AM Molecular Basis of Vascular Diversity This session is from Vascular Biology Room: Eldorado A Speaker 7 of 8 Marco Castro, Uppsala University, Sweden Short Talk: Endothelial Loss of CDC42 Elicits Cerebral Vascular Malformations and Increases MEKK3-Dependent KLF2/4 Expression
Wednesday, February 28 \| 8:00AM - 11:15AM Molecular Basis of Vascular Diversity This session is from Vascular Biology Room: Eldorado A Speaker 8 of 8 Joseph M. Rutkowski, Texas A&M College of Medicine, USA Short Talk: Enhancing Renal Lymphatic Expansion Prevents Hypertension in Mice
Wednesday, February 28 \| 11:00AM - 5:00PM On Own for Lunch
Wednesday, February 28 \| 11:00AM - 1:00PM Poster Setup Room: Anasazi Ballroom
Wednesday, February 28 \| 1:00PM - 10:00PM Poster Viewing Room: Anasazi Ballroom
Wednesday, February 28 \| 2:30PM - 4:30PM Workshop: Blood-Brain Barrier Development and Maintenance in Health and Disease This session is from Vascular Biology Room: Eldorado A Speaker 1 of 10 * Dritan Agalliu, Columbia University Medical Center, USA
Wednesday, February 28 \| 2:30PM - 4:30PM Workshop: Blood-Brain Barrier Development and Maintenance in Health and Disease This session is from Vascular Biology Room: Eldorado A Speaker 2 of 10 * Peetra Ulrica Magnusson, Uppsala University, Sweden
Wednesday, February 28 \| 2:30PM - 4:30PM Workshop: Blood-Brain Barrier Development and Maintenance in Health and Disease This session is from Vascular Biology Room: Eldorado A Speaker 3 of 10 Ruchi Bajpai, University of Southern California, USA Cranial Pericytes Derived from Neural Crest Cells Reveal a Pericyte-Specific Functional Defect in Alzheimer’s Disease
Wednesday, February 28 \| 2:30PM - 4:30PM Workshop: Blood-Brain Barrier Development and Maintenance in Health and Disease This session is from Vascular Biology Room: Eldorado A Speaker 4 of 10 Ayal Ben-Zvi, Hebrew University of Jerusalem, Israel Brain Barrier Pathology in Neuropsychiatric Lupus (NPSLE)
Wednesday, February 28 \| 2:30PM - 4:30PM Workshop: Blood-Brain Barrier Development and Maintenance in Health and Disease This session is from Vascular Biology Room: Eldorado A Speaker 5 of 10 Lei Liu Conze, Uppsala University, Sweden Dynamic Molecular Signatures of Cerebral Blood Vessel during Blood Brain Barrier Development
Wednesday, February 28 \| 2:30PM - 4:30PM Workshop: Blood-Brain Barrier Development and Maintenance in Health and Disease This session is from Vascular Biology Room: Eldorado A Speaker 6 of 10 Selasi Dankwa, Center for Infectious Disease Research, USA Identifying Host Kinases and Inhibitors that Regulate Barrier Properties in Human Brain Endothelial Cells
Wednesday, February 28 \| 2:30PM - 4:30PM Workshop: Blood-Brain Barrier Development and Maintenance in Health and Disease This session is from Vascular Biology Room: Eldorado A Speaker 7 of 10 Louise Delsing, University of Skövde, Sweden A Human iPSC-Derived Model to Investigate Blood-Brain Barrier Specification of Endothelial Cells
Wednesday, February 28 \| 2:30PM - 4:30PM Workshop: Blood-Brain Barrier Development and Maintenance in Health and Disease This session is from Vascular Biology Room: Eldorado A Speaker 8 of 10 Evelyn M. Hoover, University of California, Irvine, USA The Vascular Immune Response to Infection Differs in the Brain and the Periphery
Wednesday, February 28 \| 2:30PM - 4:30PM Workshop: Blood-Brain Barrier Development and Maintenance in Health and Disease This session is from Vascular Biology Room: Eldorado A Speaker 9 of 10 Andrei V. Karginov, University of Illinois at Chicago, USA Barrier-Enhancing Function of Src Kinase in Endothelial Cells
Wednesday, February 28 \| 2:30PM - 4:30PM Workshop: Blood-Brain Barrier Development and Maintenance in Health and Disease This session is from Vascular Biology Room: Eldorado A Speaker 10 of 10 Joppe Oldenburg, Uppsala University, Sweden Identifying Novel Small Molecule Drugs for Cerebral Cavernous Malformation Treatment
Wednesday, February 28 \| 4:30PM - 5:00PM Coffee Available Room: Concourse
Wednesday, February 28 \| 5:00PM - 7:00PM Mitochondria and Diabetic Complications Room: Eldorado B Speaker 1 of 6 * Charles E. Alpers, University of Washington, USA
Wednesday, February 28 \| 5:00PM - 7:00PM Mitochondria and Diabetic Complications Room: Eldorado B Speaker 2 of 6 * Farhad Danesh, University of Texas MD Anderson Cancer Center, USA
Wednesday, February 28 \| 5:00PM - 7:00PM Mitochondria and Diabetic Complications Room: Eldorado B Speaker 3 of 6 Patrick J. Pagano, University of Pittsburgh, USA ROS in Vascular Phenotypic Switching and Disease, Target Nox!
Wednesday, February 28 \| 5:00PM - 7:00PM Mitochondria and Diabetic Complications Room: Eldorado B Speaker 4 of 6 Karin Agnes Maria Jandeleit-Dahm, Monash University, Australia The Role of Reactive Oxygen Species in Diabetic Complications
Wednesday, February 28 \| 5:00PM - 7:00PM Mitochondria and Diabetic Complications Room: Eldorado B Speaker 5 of 6 Kumar Sharma, USA Mitochondrial ROS: Friend or Foe?
Wednesday, February 28 \| 5:00PM - 7:00PM Mitochondria and Diabetic Complications Room: Eldorado B Speaker 6 of 6 Jay C. Jha, Monash University, Australia Short Talk: NADPH-Oxidase NOX5 Aggravates Renal Injury in Human Diabetic Nephropathy
Wednesday, February 28 \| 5:00PM - 7:00PM Oxidative Stress and Diabetic Complications This session is from Vascular Biology Room: Eldorado B Speaker 1 of 5 * Costantino Iadecola, Weill Cornell Medicine, USA
Wednesday, February 28 \| 5:00PM - 7:00PM Oxidative Stress and Diabetic Complications This session is from Vascular Biology Room: Eldorado B Speaker 2 of 5 Christer Betsholtz, Uppsala University, Sweden A Molecular Atlas of the Blood-Brain Barrier as Revealed by Single Cell RNA Sequencing and Quantitative Proteomics
Wednesday, February 28 \| 5:00PM - 7:00PM Oxidative Stress and Diabetic Complications This session is from Vascular Biology Room: Eldorado B Speaker 3 of 5 Elisabetta Dejana, Uppsala University, Sweden Transcriptional Regulation of the Blood-Brain Barrier in Health and Disease
Wednesday, February 28 \| 5:00PM - 7:00PM Oxidative Stress and Diabetic Complications This session is from Vascular Biology Room: Eldorado B Speaker 4 of 5 Dritan Agalliu, Columbia University Medical Center, USA Cell Biological Mechanisms of Blood-Brain Barrier Breakdown in Neurological Disease
Wednesday, February 28 \| 5:00PM - 7:00PM Oxidative Stress and Diabetic Complications This session is from Vascular Biology Room: Eldorado B Speaker 5 of 5 Monica Manglani, NINDS, National Institutes of Health, USA Short Talk: Peptide-Specific Engagement of Cerebrovascular Endothelial Cells Promotes Dysfunctional Calcium Signaling during Experimental Cerebral Malaria
Wednesday, February 28 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Anasazi Ballroom No registration fees are used to fund alcohol served at this function.
Wednesday, February 28 \| 7:30PM - 10:00PM Poster Session 3 Room: Anasazi Ballroom
Thursday, March 01 \| 7:00AM - 8:00AM Breakfast Room: Anasazi Ballroom
Thursday, March 01 \| 8:00AM - 11:45AM Inflammation, the Vasculature and Diabetic Complications (Jo int) Room: Eldorado Grand Ballroom Speaker 1 of 11 * Anil Karihaloo, Novo Nordisk A/S, USA
Thursday, March 01 \| 8:00AM - 11:45AM Inflammation, the Vasculature and Diabetic Complications (Jo int) Room: Eldorado Grand Ballroom Speaker 2 of 11 * Michael Simons, Yale University, USA
Thursday, March 01 \| 8:00AM - 11:45AM Inflammation, the Vasculature and Diabetic Complications (Jo int) Room: Eldorado Grand Ballroom Speaker 3 of 11 Andrew J. Murphy, Baker Heart Research Institute, Australia Hematopoietic Progenitor Cells in Diabetic Complications
Thursday, March 01 \| 8:00AM - 11:45AM Inflammation, the Vasculature and Diabetic Complications (Jo int) Room: Eldorado Grand Ballroom Speaker 4 of 11 Mark E. Cooper, Monash University, Australia An Unrecognized Role for the Adaptive Immune System in Vision-Threatening Neovascular Retinopathies
Thursday, March 01 \| 8:00AM - 11:45AM Inflammation, the Vasculature and Diabetic Complications (Jo int) Room: Eldorado Grand Ballroom Coffee Break
Thursday, March 01 \| 8:00AM - 11:45AM Inflammation, the Vasculature and Diabetic Complications (Jo int) Room: Eldorado Grand Ballroom Speaker 6 of 11 Martin Schwartz, Yale School of Medicine, USA Endothelial Fluid Shear Stress Responses in Vascular Remodeling and Atherosclerosis
Thursday, March 01 \| 8:00AM - 11:45AM Inflammation, the Vasculature and Diabetic Complications (Jo int) Room: Eldorado Grand Ballroom Speaker 7 of 11 Thomas J. Schall, ChemoCentryx, Inc., USA Targeting CCR2 for the Treatment of Renal Diseases
Thursday, March 01 \| 8:00AM - 11:45AM Inflammation, the Vasculature and Diabetic Complications (Jo int) Room: Eldorado Grand Ballroom Speaker 8 of 11 Kyung Lee, Icahn School of Medicine at Mount Sinai, USA Short Talk: Leucine Rich alpha-2-Glycoprotein 1 (LRG1) Is Increased in Diabetic Kidneys and Is a Driver of Angiogenesis and Progression of Diabetic Glomerulopathy
Thursday, March 01 \| 8:00AM - 11:45AM Inflammation, the Vasculature and Diabetic Complications (Jo int) Room: Eldorado Grand Ballroom Speaker 9 of 11 Jill Badin, Indiana University School of Medicine, USA Short Talk: Diabetes Exacerbates Coronary Atherosclerosis and Calcification in Ossabaw Miniature Swine with Metabolic Syndrome
Thursday, March 01 \| 8:00AM - 11:45AM Inflammation, the Vasculature and Diabetic Complications (Jo int) Room: Eldorado Grand Ballroom Speaker 10 of 11 Ingrid Fleming, Goethe University Frankfurt, Germany Short Talk: Inhibition of Soluble Epoxide Hydrolase Prevents Diabetic Retinopathy
Thursday, March 01 \| 8:00AM - 11:45AM Inflammation, the Vasculature and Diabetic Complications (Jo int) Room: Eldorado Grand Ballroom Speaker 11 of 11 Reiner Alois Wimmer, Institute of Molecular Biotechnology Austria, Austria Short Talk: Human Blood Vessel Organoids: A New Model for Diabetic Vasculopathy
Thursday, March 01 \| 11:15AM - 5:00PM On Own for Lunch
Thursday, March 01 \| 4:30PM - 5:00PM Coffee Available Room: Concourse
Thursday, March 01 \| 5:00PM - 7:15PM Vasoactive Hormones in Diabetic Complications/Hemodynamics a nd Endothelial Pathology (Joint) Room: Eldorado Ballroom Speaker 1 of 6 * Christer Betsholtz, Uppsala University, Sweden
Thursday, March 01 \| 5:00PM - 7:15PM Vasoactive Hormones in Diabetic Complications/Hemodynamics a nd Endothelial Pathology (Joint) Room: Eldorado Ballroom Speaker 2 of 6 * Susan Quaggin, Northwestern University, USA
Thursday, March 01 \| 5:00PM - 7:15PM Vasoactive Hormones in Diabetic Complications/Hemodynamics a nd Endothelial Pathology (Joint) Room: Eldorado Ballroom Speaker 3 of 6 Rama Natarajan, Beckman Research Institute of City of Hope, USA Linking LncRNAs with Diabetic Complications and Angiotensin II Actions
Thursday, March 01 \| 5:00PM - 7:15PM Vasoactive Hormones in Diabetic Complications/Hemodynamics a nd Endothelial Pathology (Joint) Room: Eldorado Ballroom Speaker 4 of 6 Susan Gurley, Oregon Health and Science University, USA Angiotensin II: Tissue-Selective Effects
Thursday, March 01 \| 5:00PM - 7:15PM Vasoactive Hormones in Diabetic Complications/Hemodynamics a nd Endothelial Pathology (Joint) Room: Eldorado Ballroom Speaker 5 of 6 Merlin Christopher Thomas, Monash University, Australia Novel Interactions with the Receptor for Advanced Glycation End-products in Mediating Pro-inflammatory Signalling
Thursday, March 01 \| 5:00PM - 7:15PM Vasoactive Hormones in Diabetic Complications/Hemodynamics a nd Endothelial Pathology (Joint) Room: Eldorado Ballroom Speaker 6 of 6 Tatiana V. Petrova, CHUV, University of Lausanne, Switzerland Endothelial Cell Responses to Biomechanical Forces in Lymphatics
Thursday, March 01 \| 7:15PM - 7:30PM Meeting Wrap-Up: Outcomes and Future Directions (Organizers) (Joint) Room: Eldorado Ballroom
Thursday, March 01 \| 7:30PM - 8:30PM Social Hour with Lite Bites Room: Anasazi Ballroom No registration fees are used to fund alcohol served at this function.
Thursday, March 01 \| 8:00PM - 11:00PM Entertainment Room: Anasazi Ballroom Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.
Thursday, March 01 \| 8:00PM - 11:00PM Cash Bar Room: Anasazi Ballroom
Friday, March 02 \| 10:24AM - 10:24AM Departure *Session Chair.